CClinicalTrials.gg
CompletedNCT01480037Updated Jan 14, 2015

Genetic and Physiological Aspects of Oxidative Profile in Sleep and Well-succeed Aging

An observational study in Aging; Without Mention of Psychosis, sponsored by Associação Fundo de Incentivo à Pesquisa. Completed at 1 site in Brazil. Open to male participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-14.

Sponsored by Associação Fundo de Incentivo à Pesquisa · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
38
Ages
20 Years and older
Sex
Male
01

Study summary

The present study proposes the characterization of sleep patterns of healthy young adults, elderly individuals and individuals above 85 years old, using polysomnographic recordings, in order to clarify the importance of sleep in longevity. Furthermore, this study intends to analyze the oxidative stress-related gene expression in peripheral blood of the three studied groups, using the Superarray - RT2 Profiler" PCR Array System. After the identification of genes whose expression pattern among groups suggest a more specific role in longevity, the mechanisms of gene expression regulation, including DNA methylation patterns and microRNA expression, as well as the possible genomic sources of variation in these genes will be investigated. In addition, the oldest individual (105 years-old) will have his whole genome sequenced using next-generation sequencing technology, in order to identify rare variants associated with longevity. Subsequently, the effect of the polymorphisms and rare variants identified will be confirmed in an expanded sample constituted of individuals with various age-ranges. The study will provide a better characterization of molecular and physiological mechanisms involved in longevity, hoping to contribute to the development of more advanced clinical tools, capable to offer a better quality of life for the elderly.

Read the detailed description

In the last decades, the increase in life expectancy highlights the world population aging as an irreversible process. The oxidative stress hypothesis of aging suggests that accumulation of oxidative damage during lifespan may be related to loss of cellular functions, a process normally associated with senescence. However, it has been proposed that individuals who live longer in a successful manner tend to be more adapted against aging physiological changes. Sleep is essential in maintaining health and well-being. Growing evidence suggests interrelationships between oxidative stress and sleep, while the latter is an important mechanism involved in redox balance maintenance. Therefore, the present study proposes the characterization of sleep patterns of healthy young adults, elderly individuals and individuals above 85 years old, using polysomnographic recordings, in order to clarify the importance of sleep in longevity. Furthermore, this study intends to analyze the oxidative stress-related gene expression in peripheral blood of the three studied groups, using the Superarray - RT2 Profiler" PCR Array System. After the identification of genes whose expression pattern among groups suggest a more specific role in longevity, the mechanisms of gene expression regulation, including DNA methylation patterns and microRNA expression, as well as the possible genomic sources of variation in these genes will be investigated. In addition, the oldest individual (105 years-old) will have his whole genome sequenced using next-generation sequencing technology, in order to identify rare variants associated with longevity. Subsequently, the effect of the polymorphisms and rare variants identified will be confirmed in an expanded sample constituted of individuals with various age-ranges. The study will provide a better characterization of molecular and physiological mechanisms involved in longevity, hoping to contribute to the development of more advanced clinical tools, capable to offer a better quality of life for the elderly.

02

Conditions studied

  • Aging; Without Mention of Psychosis

Browse trials for

03

In context

Psychotic Disorders

1,626 studies on the registry are indexed under Psychotic Disorders; 293 are open to participants now.

This study's enrollment of 38 is below the median of 150 across 245 observational studies indexed under Psychotic Disorders.

Browse Psychotic Disorders studies →

Lead sponsor

Associação Fundo de Incentivo à Pesquisa is the lead sponsor of 22 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Residents of São Paulo city, Brazil

Inclusion criteria

  • men aged between 20-30 years-old,
  • 60-70 years-old and above 90 years-old

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled chronic disease (cancer, cardiopathy, type 2 diabetes)
  • neurological and/or psychiatric antecedents
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
38 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Elderly

    Individuals between 60 and 70 years-old

  • Long-lived

    Individuals above 85 years-old

  • Young

    Individuals between 20 and 30 years-old

06

What researchers measure

Primary outcomes

  1. Polysomnography parameters

    Time frame: 1 night

  2. Gene expression data

    Time frame: 1 day

07

Study locations

1 site
  • Associação Fundo de Incentivo à Pesquisa
    São Paulo, 04024002, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01480037
Lead sponsor
Associação Fundo de Incentivo à Pesquisa
Responsible party
Diego Robles Mazzotti (Diego Robles Mazzotti, Associação Fundo de Incentivo à Pesquisa) — Principal investigator
First posted
Nov 28, 2011
Start date
Mar 2010
Primary completion
Jun 2011
Completion
Feb 2013
Last update
Jan 14, 2015

Study contacts

Sergio Tufik, MD PhD
study director · Associação Fundo de Incentivo à Pesquisa

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion